• Expansion enhances Clariant’s global production network of isethionates mild surfactants – the Hostapon® SCI range
  • Supports personal care brands and formulators as consumers look for new mildness and hygiene claims in applications such as syndet beauty bars, body washes and cream shampoos
  • Additional capacity available early 2021

Clariant is expanding production capacity for its isethionates derivatives - Hostapon SCI - mild surfactants to support the increasing shift by personal care formulators and brands towards using mild surfactants to differentiate applications. It also supports the growing consumer trend for hygiene products. The investment at facilities in Europe and the USA will bring additional capacity on stream during Q1 2021.

“As one of the leading company for specialty chemicals in personal care, Clariant continues to invest and support the latest trends in the sector. Mild surfactants are a growing sector driven by consumers seeking new mildness claims, invaluable in helping formulators to answer needs for mild cleansing hygiene, sensitive skin solutions, solid formats and more natural ingredients,” comments Christian Vang, Global Head of Business Unit Industrial & Consumer Specialties.

Clariant’s Hostapon SCI grades are natural, anionic mild surfactants. Plant-based, they are non-irritant, ultra-mild and compliant with a number of industry-recognized ecolabels, and create formulations with creamy, stable foams. They form part of Clariant’s broad portfolio of mild surfactants, the most comprehensive in the industry, for skin cleansing, hair care and baby care applications. Each one brings high level cleaning performance and specific foam types or thickening behavior to products, supported by different formulation benefits and consumer features.

As a global expansion, the investment targets capacity increase and general modernization of current facilities at the Mount Holly (USA) and Tarragona (Spain) manufacturing sites. The general asset modernization will optimize energy consumption and also aggregate options for new SI grades (different Carbon-chains).

“We are pleased to announce this long-term strategic investment. Together with our introduction in recent years of Glucamides sugar surfactant technology, it further positions Clariant as one of the innovative leaders for the future of mild surfactants, as they become increasingly popular among our personal care customers in their development of milder and healthier solutions,” adds Ralf Zerrer, Global Head of Strategic Marketing and Innovation Business Unit Industrial & Consumer Specialties.


Clariant is a focused and innovative specialty chemical company based in Muttenz, near Basel/Switzerland. On 31 December 2019, the company employed a total workforce of 17 223. In the financial year 2019, Clariant recorded sales of CHF 4.399 billion for its continuing businesses. The company reports in three business areas: Care Chemicals, Catalysis and Natural Resources. Clariant’s corporate strategy is based on five pillars: focus on innovation and R&D, add value with sustainability, reposition portfolio, intensify growth, and increase profitability. www.clariant.com
4426 0 gross clariant
Zurück nach oben

Wir nutzen Cookies auf unserer Website. Einige von ihnen sind essenziell für den Betrieb der Seite, während andere uns helfen, diese Website und die Nutzererfahrung zu verbessern (Tracking Cookies). Sie können selbst entscheiden, ob Sie die Cookies zulassen möchten. Bitte beachten Sie, dass bei einer Ablehnung womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen.